Dynavax Technologies Corporation (DVAX)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 49,445 | 50,167 | 262,153 | 173,572 | 13,910 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $49,445K ÷ $—K
= —
Based on the provided data, the payables turnover ratio for Dynavax Technologies Corporation is not available for the years ranging from December 31, 2020, to December 31, 2024. This lack of information on payables turnover makes it challenging to assess the efficiency with which the company is managing its accounts payable and paying its suppliers during these years. It is important for stakeholders to have access to this ratio to evaluate the company's liquidity and operational efficiency better.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
Dynavax Technologies Corporation
DVAX
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
19.54
Amphastar P
AMPH
11.74
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
8.33
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
8.82
Catalyst Pharmaceuticals Inc
CPRX
—